Seroprevalence of human enterovirus A71 in Guangzhou, China, 2019–2021

IF 3.5 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Huimin Lian , Huimin Jiang , Lina Yi , Jing Sun , Huaping Xie , Ming Qiu , Limei Sun , Huifang Lin , Mingda Yang , Lin Qu , Haiyi Yang , Jing Lu , Hanri Zeng
{"title":"Seroprevalence of human enterovirus A71 in Guangzhou, China, 2019–2021","authors":"Huimin Lian ,&nbsp;Huimin Jiang ,&nbsp;Lina Yi ,&nbsp;Jing Sun ,&nbsp;Huaping Xie ,&nbsp;Ming Qiu ,&nbsp;Limei Sun ,&nbsp;Huifang Lin ,&nbsp;Mingda Yang ,&nbsp;Lin Qu ,&nbsp;Haiyi Yang ,&nbsp;Jing Lu ,&nbsp;Hanri Zeng","doi":"10.1016/j.bsheal.2023.05.002","DOIUrl":null,"url":null,"abstract":"<div><p>Enterovirus A71 (EV-A71) is a significant hand-foot-mouth disease (HFMD) etiology. The inactivated EV-A71 vaccines were approved in China in 2016. However, the seroprevalence of EV-A71 after the vaccine application and its potential association with the EV-A71 epidemic in the population are rarely studied. In this study, we analyzed the incidence of EV-A71 infection and seroepidemiology in Guangzhou City, China. From 2019 to 2021, 167,920 clinically confirmed HFMD cases were reported in Guangzhou. In 6,868 enterovirus-positive samples, Coxsackievirus A6 and Coxsackievirus A16 were dominant genotypes, and only 3 EV-A71-positive samples were detected, highlighting the deficient epidemic activity of EV-A71. Microneutralization assay was performed on 1,000 representative serum samples. Notably, the seroprevalence and geometric mean titer (GMT) decreased significantly in 2020, and that in the &lt; 3-year age group were increased and even higher than that in 3–5-year age group in 2019 and 2021, which was contrary to our previous surveillance result and other studies in Guangzhou. Furthermore, a moderate decline of GMT level was observed following the vaccination, but the seropositive serums were still detected for 49 months after second immunization, suggesting the long-term persistence of the immunity. Our seroepidemiology study revealed relatively higher neutralizing antibody activity in the susceptible population after the EV-A71 vaccine was adopted in 2016 in Guangzhou. It may be one of the reasons for the lower epidemic activity of EV-A71 in Guangzhou from 2019 to 2021.</p></div>","PeriodicalId":36178,"journal":{"name":"Biosafety and Health","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biosafety and Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590053623000526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Enterovirus A71 (EV-A71) is a significant hand-foot-mouth disease (HFMD) etiology. The inactivated EV-A71 vaccines were approved in China in 2016. However, the seroprevalence of EV-A71 after the vaccine application and its potential association with the EV-A71 epidemic in the population are rarely studied. In this study, we analyzed the incidence of EV-A71 infection and seroepidemiology in Guangzhou City, China. From 2019 to 2021, 167,920 clinically confirmed HFMD cases were reported in Guangzhou. In 6,868 enterovirus-positive samples, Coxsackievirus A6 and Coxsackievirus A16 were dominant genotypes, and only 3 EV-A71-positive samples were detected, highlighting the deficient epidemic activity of EV-A71. Microneutralization assay was performed on 1,000 representative serum samples. Notably, the seroprevalence and geometric mean titer (GMT) decreased significantly in 2020, and that in the < 3-year age group were increased and even higher than that in 3–5-year age group in 2019 and 2021, which was contrary to our previous surveillance result and other studies in Guangzhou. Furthermore, a moderate decline of GMT level was observed following the vaccination, but the seropositive serums were still detected for 49 months after second immunization, suggesting the long-term persistence of the immunity. Our seroepidemiology study revealed relatively higher neutralizing antibody activity in the susceptible population after the EV-A71 vaccine was adopted in 2016 in Guangzhou. It may be one of the reasons for the lower epidemic activity of EV-A71 in Guangzhou from 2019 to 2021.

2019-2021年广州地区人肠道病毒A71血清阳性率分析
肠病毒A71 (EV-A71)是一种重要的手足口病病原。EV-A71灭活疫苗于2016年在中国获得批准。然而,疫苗接种后EV-A71的血清阳性率及其与人群中EV-A71流行的潜在关联的研究很少。在本研究中,我们分析了中国广州市EV-A71感染的发病率和血清流行病学。2019 - 2021年,广州市累计报告手足口病临床确诊病例167920例。在6868份肠病毒阳性样本中,柯萨奇病毒A6和柯萨奇病毒A16为优势基因型,EV-A71阳性样本仅检测到3份,说明EV-A71的流行活性不足。对1000份有代表性的血清样品进行微量中和试验。值得注意的是,血清阳性率和几何平均滴度(GMT)在2020年显著下降;2019年和2021年3岁年龄组有所增加,甚至高于3- 5岁年龄组,这与我们之前在广州的监测结果和其他研究结果相反。此外,在接种疫苗后,观察到GMT水平中度下降,但在第二次免疫后49个月仍检测到血清阳性血清,表明免疫的长期持久性。我们的血清流行病学研究显示,2016年广州地区接种EV-A71疫苗后,易感人群中和抗体活性相对较高。这可能是2019 - 2021年广州EV-A71疫情活动较低的原因之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biosafety and Health
Biosafety and Health Medicine-Infectious Diseases
CiteScore
7.60
自引率
0.00%
发文量
116
审稿时长
66 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信